Reuben Matalon

The University of Texas Medical Branch at Galveston — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

61h-index10.8kcitations344works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism and Genetic Disorders(115), Folate and B Vitamins Research(57), Advanced MRI Techniques and Applications(56), Lysosomal Storage Disorders Research(46), Mitochondrial Function and Pathology(38)

Publications342 total

Canavan disease
Elsevier eBooks·2024
The mucopolysaccharidoses
Elsevier eBooks·2024· 1 cited
List of Contributors
Elsevier eBooks·2024Open Access
The mucolipidoses
Elsevier eBooks·2024
Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene
iScience·2022· 14 citedOpen Access
Stem Cell Therapy: Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs (Adv. Sci. 23/2020)
Advanced Science·2020· 1 citedOpen Access
Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Advanced Science·2020· 31 citedOpen Access
List of contributors
Elsevier eBooks·2020
The mucopolysaccharidoses
Elsevier eBooks·2020· 1 cited
Canavan disease
Elsevier eBooks·2020· 1 cited
The mucolipidoses
Elsevier eBooks·2020
The discoverer of Canavan syndrome gene: how problems of diagnosis and treatment are being changed over time
2019
Table 1. [Molecular Genetic Testing Used in Canavan Disease].
2018
Identification of novel candidate disease genes from de novo exonic copy number variants
Genome Medicine·2017· 62 citedOpen Access
Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease
JCI Insight·2017· 66 citedOpen Access
Additional file 8: of Identification of novel candidate disease genes from de novo exonic copy number variants
Figshare·2017Open Access
Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids
European Journal of Clinical Nutrition·2016· 27 citedOpen Access
Xq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder
European Journal of Medical Genetics·2016· 23 cited
351. Efficacious Non-Oligodendrocyte Gene Therapy Suggests a New Dogma About CNS Compartmentalization of NAA Metabolism and Supports a Metabolic Sink Theory
Molecular Therapy·2016Open Access
58. Pushing the Limits for Canavan Gene Therapy into Adulthood: Is There an Age Limit for Gene Therapy in CNS Disorders?
Molecular Therapy·2016· 1 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Albert Dorfman(11), Richard Koch(8), Bobbye Rouse(8), Stephen K. Tyring(7), Felix de la Cruz(7), Rajinder Kaul(6), William Hanley(6), Harvey L. Levy(6), Colleen Azen(6), K. Michals(5), Sankar Surendran(5), Sylvia Szucs(4), Toby Johnson(4), Peter L. Rady(4), James J. Grady(4), J. Casanova(3), Friedrich K. Trefz(3), Minerva Deanching(2), P. Gashkoff(2), Guang Ping Gao(2)